STOCK TITAN
  1. Home
  2. Sec-filings
  3. TOVX
  4. [ARS] Theriva Biologics, Inc. SEC Filing

[ARS] Theriva Biologics, Inc. SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Theriva Biologics, Inc.

ARS Filing - Theriva Biologics, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Theriva Biologics, Inc. (TOVX)

Acceptance Date: 2025-07-09T16:55:51.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock TOVX logo
THERIVA BIOLOGICS INC

NYSE:TOVX

TOVX Rankings

#6395 Ranked by Market Cap
N/A Ranked by Dividends

TOVX Latest News

Aug 11, 2025
Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results
May 27, 2025
Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at ASCO 2025 and Investigator Meeting to Review Topline Data from the VIRAGE Phase 2b Trial of VCN-01 in Metastatic Pancreatic Cancer
May 14, 2025
Theriva™ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results
May 8, 2025
Theriva Biologics Announces Closing of $7.5 Million Public Offering
May 7, 2025
Theriva Biologics Announces Pricing of $7.5 Million Public Offering

TOVX Latest SEC Filings

Aug 11, 2025
[10-Q] Theriva Biologics, Inc. Quarterly Earnings Report
Aug 11, 2025
[8-K] Theriva Biologics, Inc. Reports Material Event
Jul 31, 2025
[SCHEDULE 13G] Theriva Biologics, Inc. SEC Filing
Jul 9, 2025
[DEF 14A] Theriva Biologics, Inc. Definitive Proxy Statement
Jun 25, 2025
[8-K] Theriva Biologics, Inc. Reports Material Event

TOVX Stock Data

4.12M
9.58M
0.14%
12.33%
1.01%
Biotechnology
Pharmaceutical Preparations
Link
United States
ROCKVILLE